[cnbc 3000089408]
Richard Pops, Alkermes CEO, discusses getting FDA approval for developing better drugs, with Mad Money’s Cramer.
With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.
Video © and provided by CNBC.
Be the first to comment